CAV1通过调节CaSR和ER压力来揭示甲病的新型治疗点
Yang Li1, Baoyu Yang2, Haozhen Wang2
1Department of Cell Biology and Genetics, Shenyang Medical College, 146 Huanghe North Street, Shenyang 110034, China; Key Laboratory of Renal Calcification Disease Prevention and Treatment, 146 Huanghe North Street, Shenyang 110034, China.
概括
卡维林-1 (CAV1) 通过调节感受受体 (CaSR) 和内质网膜 (ER) 压力来保护结石的形成. 过度表达CAV1可以减轻水晶诱导的细胞损伤,这表明它是结石病的治疗点.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 结石 (结石) 涉及复杂的晶体细胞相互作用.
- 细胞内膜网膜 (ER) 应激受影响,但其在结石形成中的机制尚不清楚.
- 氧化单 (COM) 晶体是结石的常见原因.
研究的目的:
- 为了阐明COM晶体诱导的结石形成中ER应激的机制.
- 研究感应受体 (CaSR) 和洞穴蛋白-1 (CAV1) 在这个过程中的作用.
- 为了确定结石病的潜在治疗点.
主要方法:
- 使用HK-2管状上皮细胞和体内模型.
- 研究了COM晶体对细胞内Ca2+,CaSR表达和ER压力的影响.
- 从GWAS和微阵列数据中分析了蛋白质-蛋白质相互作用网络.
- 研究了CAV1,表皮生长因子受体 (EGFR) 和AKT信号传导的作用.
- 使用了CaSR抑制剂NPS2390,CAV1过度表达,以及蛋白酶体抑制剂MG-132.
主要成果:
- COM晶体增加了细胞内Ca2+和CaSR的表达,在HK-2细胞中诱导了ER应激.
- 在网络分析中,CAV1,EGFR和焦粘附路径成为关键的交叉点.
- 接触COM降低了CAV1蛋白水平,并损害了EGFR-AKT通路,导致HK-2细胞亡.
- CAV1过度表达逆转了COM诱导的亡,ER压力和CaSR上调.
- 蛋白质酶抑制阻止了CAV1的下调,表明后翻译调节.
结论:
- CAV1对COM晶体诱导的结石形成起着保护作用.
- CAV1调节CaSR表达和ER压力,提供一种潜在的治疗策略.
- 向CAV1可能是治疗结石病的一种有前途的方法.
相关概念视频
01:17Role of ER in the Secretory Pathway
5.2K
Eukaryotic cells have a special pathway that enables communication between various intracellular membrane-bound compartments and also with the extracellular environment. This pathway is termed as the secretory pathway.
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...
5.2K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
363
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
363
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
01:25Antihypertensive Drugs: Direct Renin Inhibitors
468
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
468
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
437
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
437
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
447
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
447